Cargando…

HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress

BACKGROUND: HIV-infected patients have an increased risk of cardiovascular disease (CVD). Impaired endothelial function is an early risk factor for CVD in the general population. It is presumed that HIV infection is associated with impaired endothelial function, but results have been inconsistent. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Dysangco, Andrew, Liu, Ziyue, Stein, James H., Dubé, Michael P., Gupta, Samir K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560712/
https://www.ncbi.nlm.nih.gov/pubmed/28817706
http://dx.doi.org/10.1371/journal.pone.0183511
_version_ 1783257710220804096
author Dysangco, Andrew
Liu, Ziyue
Stein, James H.
Dubé, Michael P.
Gupta, Samir K.
author_facet Dysangco, Andrew
Liu, Ziyue
Stein, James H.
Dubé, Michael P.
Gupta, Samir K.
author_sort Dysangco, Andrew
collection PubMed
description BACKGROUND: HIV-infected patients have an increased risk of cardiovascular disease (CVD). Impaired endothelial function is an early risk factor for CVD in the general population. It is presumed that HIV infection is associated with impaired endothelial function, but results have been inconsistent. OBJECTIVES: Our objectives were to determine the relationships between HIV infection, virologic suppression with antiretroviral therapy (ART), in vivo measures of conduit artery and microvascular endothelial function, and circulating biomarkers of pathways associated with CVD. METHODS: We performed a cross-sectional analysis of three prospectively enrolled groups from a single center: 28 were HIV-infected and virologically-suppressed on a regimen of FTC/TDF/EFV (HIV+ART+), 44 were HIV-infected but not on ART (HIV+ART-), and 39 were HIV-uninfected healthy volunteers (HIV-) matched to the HIV+ART- group for age, sex, smoking status, and height. None had diabetes, uncontrolled hypertension, known CVD, or other pro-inflammatory condition. Flow mediated dilation (FMD), nitroglycerin-mediated dilation (NTGMD), reactive hyperemia velocity time integral (RHVTI), and FMD/RHVTI of the brachial artery were measured, as well as circulating biomarkers of systemic inflammation, metabolism, oxidative stress, and endothelial activation. RESULTS: No significant differences were found amongst the three groups in FMD (P = 0.46), NTGMD (P = 0.42), RHVTI (P = 0.17), and FMD/RHVTI (P = 0.22) in unadjusted comparisons. Adjusted ANOVA models which included brachial artery diameter, demographics, and conventional CVD risk factors did not appreciably change these findings. In pairwise comparisons, the HIV+ART- group had significantly higher soluble tumor necrosis factor receptor II, soluble CD163, β-2 microglobulin, interferon-γ- induced protein-10, tissue inhibitor of metalloproteinase-1, and vascular cell adhesion molecule-1 compared to the other two groups (all p<0.05). Correlates of endothelial function differed between study groups. CONCLUSION: Although untreated HIV infection was associated with elevated levels of several biomarkers of inflammation and endothelial activation, we were unable to demonstrate differences in measures of conduit artery and microvascular endothelial function in this study population.
format Online
Article
Text
id pubmed-5560712
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55607122017-08-25 HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress Dysangco, Andrew Liu, Ziyue Stein, James H. Dubé, Michael P. Gupta, Samir K. PLoS One Research Article BACKGROUND: HIV-infected patients have an increased risk of cardiovascular disease (CVD). Impaired endothelial function is an early risk factor for CVD in the general population. It is presumed that HIV infection is associated with impaired endothelial function, but results have been inconsistent. OBJECTIVES: Our objectives were to determine the relationships between HIV infection, virologic suppression with antiretroviral therapy (ART), in vivo measures of conduit artery and microvascular endothelial function, and circulating biomarkers of pathways associated with CVD. METHODS: We performed a cross-sectional analysis of three prospectively enrolled groups from a single center: 28 were HIV-infected and virologically-suppressed on a regimen of FTC/TDF/EFV (HIV+ART+), 44 were HIV-infected but not on ART (HIV+ART-), and 39 were HIV-uninfected healthy volunteers (HIV-) matched to the HIV+ART- group for age, sex, smoking status, and height. None had diabetes, uncontrolled hypertension, known CVD, or other pro-inflammatory condition. Flow mediated dilation (FMD), nitroglycerin-mediated dilation (NTGMD), reactive hyperemia velocity time integral (RHVTI), and FMD/RHVTI of the brachial artery were measured, as well as circulating biomarkers of systemic inflammation, metabolism, oxidative stress, and endothelial activation. RESULTS: No significant differences were found amongst the three groups in FMD (P = 0.46), NTGMD (P = 0.42), RHVTI (P = 0.17), and FMD/RHVTI (P = 0.22) in unadjusted comparisons. Adjusted ANOVA models which included brachial artery diameter, demographics, and conventional CVD risk factors did not appreciably change these findings. In pairwise comparisons, the HIV+ART- group had significantly higher soluble tumor necrosis factor receptor II, soluble CD163, β-2 microglobulin, interferon-γ- induced protein-10, tissue inhibitor of metalloproteinase-1, and vascular cell adhesion molecule-1 compared to the other two groups (all p<0.05). Correlates of endothelial function differed between study groups. CONCLUSION: Although untreated HIV infection was associated with elevated levels of several biomarkers of inflammation and endothelial activation, we were unable to demonstrate differences in measures of conduit artery and microvascular endothelial function in this study population. Public Library of Science 2017-08-17 /pmc/articles/PMC5560712/ /pubmed/28817706 http://dx.doi.org/10.1371/journal.pone.0183511 Text en © 2017 Dysangco et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Dysangco, Andrew
Liu, Ziyue
Stein, James H.
Dubé, Michael P.
Gupta, Samir K.
HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress
title HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress
title_full HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress
title_fullStr HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress
title_full_unstemmed HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress
title_short HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress
title_sort hiv infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560712/
https://www.ncbi.nlm.nih.gov/pubmed/28817706
http://dx.doi.org/10.1371/journal.pone.0183511
work_keys_str_mv AT dysangcoandrew hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress
AT liuziyue hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress
AT steinjamesh hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress
AT dubemichaelp hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress
AT guptasamirk hivinfectionantiretroviraltherapyandmeasuresofendothelialfunctioninflammationmetabolismandoxidativestress